Research & KnowledgeEvent: September 2, 2026
Delve Bio published findings in the Nature Medicine publication showing that Delve Detect outperformed conventional diagnostic testing methods for CNS infections.
Published
Signal category
Research & Knowledge
Quote
“Since Delve Detect outperformed conventional diagnostic testing methods, this enables physicians to make more informed treatment decisions for their patients with CNS infections. See full details in the Nature Medicine publication.”
— Jeffrey Field, M.S., MBA|Delve Bio team
Company
Delve Bio
Providing Molecular Insights for the Precision Care of the Sickest Patients
- Industry
- Biotechnology Research
- Location
- Boston, US
- Company size
- 43 employees
We are a well-funded biotech company backed by some of the most experienced operators and investors in the biotech industry. Our co-founders are highly experienced researchers, clinicians, and entrepreneurs, on a mission to improve precision medicine with cutting-edge genomic technology.
Founded 2022